| scholarly article | Q13442814 |
| P50 | author | Ismini Lasithiotaki | Q88766829 |
| P2093 | author name string | Katerina M Antoniou | |
| Nikolaos Tzanakis | |||
| Katerina D Samara | |||
| Athina Trachalaki | |||
| Eliza Tsitoura | |||
| Irini Charalambous | |||
| P2860 | cites work | Hallmarks of Cancer: The Next Generation | Q22252312 |
| Evidence of IL-18 as a novel angiogenic mediator | Q24291472 | ||
| Immune cell promotion of metastasis | Q26991724 | ||
| Inflammasomes: mechanism of action, role in disease, and therapeutics | Q27001186 | ||
| Alternative activation of macrophages | Q27860939 | ||
| Inflammation and cancer: back to Virchow? | Q28036756 | ||
| Non-canonical inflammasome activation targets caspase-11 | Q28506831 | ||
| NF-kappaB in lung cancer, a carcinogenesis mediator and a prevention and therapy target | Q28611413 | ||
| Macrophages: Obligate Partners for Tumor Cell Migration, Invasion, and Metastasis | Q29396371 | ||
| Cancer statistics, 2016 | Q29547383 | ||
| Nuclear factor-kappaB in cancer development and progression | Q29547879 | ||
| Activation of the NLRP3 inflammasome in dendritic cells induces IL-1beta-dependent adaptive immunity against tumors | Q29615665 | ||
| Biologic basis for interleukin-1 in disease | Q29619853 | ||
| Differential expression of Toll-like receptors on human alveolar macrophages and autologous peripheral monocytes. | Q33634527 | ||
| Proteomic and bioinformatics profile of paired human alveolar macrophages and peripheral blood monocytes. | Q33919457 | ||
| Detection of herpes simplex virus type-1 in patients with fibrotic lung diseases | Q34113496 | ||
| Ceramide upregulation causes pulmonary cell apoptosis and emphysema-like disease in mice | Q34316428 | ||
| Epigenetic control of gene expression in the lung | Q35042509 | ||
| Recombinant mutated human TNF in combination with chemotherapy for stage IIIB/IV non-small cell lung cancer: a randomized, phase III study | Q35506307 | ||
| Enhanced activity of NLRP3 inflammasome in peripheral blood cells of patients with active rheumatoid arthritis | Q36073831 | ||
| Macrophages within NSCLC tumour islets are predominantly of a cytotoxic M1 phenotype associated with extended survival. | Q50607532 | ||
| Recruited monocytic myeloid-derived suppressor cells promote the arrest of tumor cells in the premetastatic niche through an IL-1β-mediated increase in E-selectin expression. | Q51304544 | ||
| Differential expression of inflammasomes in lung cancer cell lines and tissues. | Q51637026 | ||
| Caspase-1-processed cytokines IL-1beta and IL-18 promote IL-17 production by gammadelta and CD4 T cells that mediate autoimmunity. | Q54379135 | ||
| Phenotypic characterisation of alveolar macrophages and peripheral blood monocytes in COPD | Q58840532 | ||
| Interleukin-10 inhibits interleukin-2-induced tumor necrosis factor production but does not reduce toxicity in C3H/HeN mice | Q71237162 | ||
| Acrolein-induced cell death in human alveolar macrophages | Q73614714 | ||
| Modulation of tumoricidal function in alveolar macrophages from lung cancer patients by interleukin-6 | Q73836434 | ||
| Role of VEGF-stromal cell-derived factor-1alpha/CXCL12 axis in pleural effusion of lung cancer | Q83101752 | ||
| NLRP3 inflammasome expression in idiopathic pulmonary fibrosis and rheumatoid lung | Q87036758 | ||
| Inflammation-associated immune suppression in cancer: the roles played by cytokines, chemokines and additional mediators | Q36247789 | ||
| Impact of human monocyte and macrophage polarization on NLR expression and NLRP3 inflammasome activation | Q36344806 | ||
| "Re-educating" tumor-associated macrophages by targeting NF-kappaB. | Q36699735 | ||
| Humoral immunity, inflammation and cancer | Q36727285 | ||
| Superoxide dismutase protects against apoptosis and alveolar enlargement induced by ceramide | Q36808041 | ||
| Chronic NF-κB activation links COPD and lung cancer through generation of an immunosuppressive microenvironment in the lungs | Q36905694 | ||
| Inflammasomes and rheumatic diseases: evolving concepts | Q36963836 | ||
| Tumor necrosis factor and cancer, buddies or foes? | Q37073092 | ||
| Airway inflammation and bronchial bacterial colonization in chronic obstructive pulmonary disease | Q37144323 | ||
| Cancer related inflammation: the macrophage connection | Q37151493 | ||
| Tolerance and M2 (alternative) macrophage polarization are related processes orchestrated by p50 nuclear factor kappaB. | Q37329573 | ||
| Phagocytic dysfunction of human alveolar macrophages and severity of chronic obstructive pulmonary disease | Q37332198 | ||
| Targeting inflammasome/IL-1 pathways for cancer immunotherapy | Q37370733 | ||
| IL-1α and IL-1β-producing macrophages populate lung tumor lesions in mice | Q37629006 | ||
| Inflammasomes in carcinogenesis and anticancer immune responses | Q37995072 | ||
| Tumor-associated macrophages: functional diversity, clinical significance, and open questions | Q38105286 | ||
| The role of inflammation in lung cancer. | Q38211072 | ||
| Effect of interleukin-1β inhibition with canakinumab on incident lung cancer in patients with atherosclerosis: exploratory results from a randomised, double-blind, placebo-controlled trial | Q38601785 | ||
| Pulmonary alveolar macrophages contribute to the premetastatic niche by suppressing antitumor T cell responses in the lungs | Q38882440 | ||
| IL-1β-mediated repression of microRNA-101 is crucial for inflammation-promoted lung tumorigenesis | Q38981840 | ||
| Inflammasomes and Cancer | Q39091104 | ||
| Blockade of interleukin-6 receptor suppresses the proliferation of H460 lung cancer stem cells | Q39354902 | ||
| Macrophage Polarization. | Q40463776 | ||
| Ceramide induces caspase-dependent and -independent apoptosis in A-431 cells | Q40586938 | ||
| The Impact of Exogenous Factors on Respiratory Pathogen-Induced Innate Alveolar Macrophage Responses in COPD. | Q40801306 | ||
| Heterogeneous response patterns of alveolar macrophages from patients with lung cancer by stimulation with interferon-gamma | Q40852388 | ||
| Macrophages, Inflammation, and Lung Cancer | Q41113415 | ||
| Alveolar macrophage function is altered in patients with lung cancer | Q42164579 | ||
| Impaired innate immune alveolar macrophage response and the predilection for COPD exacerbations | Q42221260 | ||
| Blood cell redistribution in the lung after administration of recombinant human granulocyte-macrophage colony-stimulating factor | Q42514595 | ||
| Tumor infiltrating lymphocytes and macrophages have a potential dual role in lung cancer by supporting both host-defense and tumor progression | Q44218092 | ||
| Reduced IL-6 levels and tumor-associated phospho-STAT3 are associated with reduced tumor development in a mouse model of lung cancer chemoprevention with myo-inositol | Q47565249 | ||
| Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease 2017 Report. GOLD Executive Summary | Q47984024 | ||
| Cutting Edge: Distinct Regulatory Mechanisms Control Proinflammatory Cytokines IL-18 and IL-1β. | Q48197204 | ||
| IL-18 is induced and IL-18 receptor alpha plays a critical role in the pathogenesis of cigarette smoke-induced pulmonary emphysema and inflammation | Q50232158 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 10 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | inflammasome complex | Q412405 |
| P304 | page(s) | e0205242 | |
| P577 | publication date | 2018-10-26 | |
| P1433 | published in | PLOS One | Q564954 |
| P1476 | title | NLRP3/Caspase-1 inflammasome activation is decreased in alveolar macrophages in patients with lung cancer | |
| P478 | volume | 13 |
| Q64071901 | Macrophage Origin, Metabolic Reprogramming and IL-1 Signaling: Promises and Pitfalls in Lung Cancer |
| Q102058920 | Scutellarin ameliorates pulmonary fibrosis through inhibiting NF-κB/NLRP3-mediated epithelial-mesenchymal transition and inflammation |
| Q91537127 | The regulatory functions of circular RNAs in osteosarcoma |
Search more.